Myomo (MYO) Gross Margin Growth (3y) (2019 - 2025)
Myomo (MYO) Gross Margin Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 264.00 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 459.00 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 21.00 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 8.00 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -316.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 73.00 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 90.00 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -3,577.00 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 113.00 |
| 10 | Myomo | 73.79 Mn | 54.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -261.00 |
| Jun 30, 2025 | -259.00 |
| Mar 31, 2025 | 60.00 |
| Dec 31, 2024 | -606.00 |
| Sep 30, 2024 | 76.00 |
| Jun 30, 2024 | -15.00 |
| Mar 31, 2024 | -1,209.00 |
| Dec 31, 2023 | -814.00 |
| Sep 30, 2023 | 1,308.00 |
| Jun 30, 2023 | 2,063.00 |
| Mar 31, 2023 | -144.00 |
| Dec 31, 2022 | -706.00 |
| Sep 30, 2022 | 2,073.00 |
| Jun 30, 2022 | 847.00 |
| Mar 31, 2022 | 118.00 |
| Dec 31, 2021 | 287.00 |
| Sep 30, 2021 | 646.00 |
| Jun 30, 2021 | 266.00 |
| Mar 31, 2021 | 784.00 |
| Dec 31, 2020 | 1,068.00 |